HOME DIAGNOSTICS, INC. [ ] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • July 12th, 2006 • Home Diagnostics Inc • Surgical & medical instruments & apparatus • New York
Home Diagnostics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities Inc. (“JPMorgan”) and Piper Jaffray & Co. (“Piper”) are acting as representatives (each a “Representative” and together, the “Representatives”), an aggregate of [ ] shares of Common Stock, par value $0.01 per share, of the Company, and the stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the Underwriters an aggregate of [ ] shares of Common Stock of the Company and, at the option of the Underwriters, up to an additional [ ] shares of Common Stock of the Company. The aggregate of [ ] shares to be sold by the Company and the Selling Stockholders is herein called the “Underwritten Shares” and the aggregate of [ ] additional shares to be sold by the Selling Stockholders is herein called the “Option Shares.” The Underwritten Shares and the
